Welcome to our dedicated page for Ormat Tech SEC filings (Ticker: ORA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ormat Technologies filings document the regulatory record for a NYSE-listed renewable energy operating company with common shares traded under ORA. Recent Form 8-K reports furnish operating and financial results, non-GAAP reconciliations, and exhibits tied to quarterly earnings releases.
The filing record also covers material definitive agreements and capital-structure disclosures, including indentures for Series A and Series B convertible senior notes due 2031. Proxy materials address shareholder voting matters, board governance, executive compensation, equity awards, and pay-versus-performance disclosures.
Migdal Insurance & Financial Holdings Ltd. has filed a Schedule 13G reporting beneficial ownership of 3,040,648 shares of Ormat Technologies, Inc. common stock, representing 5% of the class as of January 20, 2026.
The filing shows Migdal has shared voting and dispositive power over all reported shares, with no sole voting or dispositive power. The stake is held through various Migdal subsidiaries, which manage insurance, pension, provident, mutual fund and portfolio accounts, and Migdal states the shares are not held to change or influence control of Ormat.
Ormat Technologies (ORA) reported insider transactions by its GC, CCO, and Corporate Secretary. On November 7, 2025, the officer exercised 1,000 Stock Appreciation Rights (SARs) at an exercise price of $71.15 and received 368 shares, then sold 368 shares in open-market trades at a weighted average price of $112.36. On November 10, 2025, the officer exercised 1,889 SARs at $71.15 and received 721 shares, then sold 721 shares at $115.00.
Following these transactions, the officer beneficially owned 3,433 shares of common stock directly. Derivative holdings reflected remaining SARs of 962 expiring on March 1, 2028. The filing notes that the sale prices on November 7 were executed across multiple trades within the $112.35–$112.39 range.
Ormat Technologies (ORA): The Chief Financial Officer reported an open‑market sale of common stock. On 11/07/2025, the officer sold 20,000 shares (Transaction Code S) at a weighted average price of $112.725, with trades executed between $112.53 and $113.03. Following the sale, the officer beneficially owned 4,482 shares, held directly.
Ormat Technologies (ORA) reported an insider transaction on Form 4. The company’s EVP, Energy Storage & BD, sold 511 shares of common stock in an open‑market trade on November 7, 2025 at a price of $113.3 per share. Following the sale, the reporting person beneficially owns 1,110 shares, held directly.
Ormat Technologies (ORA) reported an insider transaction on a Form 4. A director sold 1,753 shares of common stock on 11/07/2025, coded S for an open-market sale at a price of $112.54 per share. Following the transaction, the insider reported 0 shares beneficially owned with direct (D) ownership. A footnote states the shares were sold in the open market on November 7, 2025.
Ormat Technologies (ORA) — Form 4 insider sale: A director reported selling 18,018 shares of common stock in open‑market transactions on 11/07/2025 at a weighted average price of $112.4247. The trades occurred across multiple executions between $112.23 and $112.775.
Following these transactions, the reporting person beneficially owned 29,650 shares, held directly.
ORA filed a Form 144 covering a proposed sale of 721 common shares, with an aggregate market value of $82,915. The shares are slated for sale on 11/10/2025 through Morgan Stanley Smith Barney LLC on the NYSE.
The 721 shares were acquired on 11/10/2025 via Stock Appreciation Rights from the issuer, with payment listed as cash. Shares outstanding were 60,781,792. Recent selling activity by Jessica Woelfel over the past three months included 368 shares on 11/07/2025 for $41,349.80, 5,611 shares on 09/29/2025 for $531,922.60, and 692 shares on 08/22/2025 for $65,442.44.
Ormat Technologies (ORA): A holder filed a Rule 144 notice to sell 511 shares of common stock through Bank Leumi on the NYSE, with an aggregate market value of $57,896.30 and an approximate sale date of 11/07/2025.
The 511 shares were acquired on 09/15/2020 via an open market purchase for cash. Over the past three months, the filer sold 9,890 shares on 11/05/2025 for gross proceeds of $1,137,350. The number of shares outstanding is 60,781,792.
ORA — Rule 144 notice of proposed share sale. A holder filed to sell 368 shares of Common stock through Morgan Stanley Smith Barney, with an aggregate market value of $41,349.80. The approximate sale date is 11/07/2025 on the NYSE.
The shares were acquired on 11/07/2025 via Stock Appreciation Rights, with cash payment. As context, 60,781,792 shares were outstanding. In the past three months, the filer sold 5,611 shares on 09/29/2025 for $531,922.60 and 692 shares on 08/22/2025 for $65,442.44.
ORA filed a Rule 144 notice for a proposed sale of 20,000 common shares. The filing lists an aggregate market value of $2,266,000 and an approximate sale date of 11/07/2025. The shares are to be sold through J.P. Morgan Securities LLC on the NYSE.
The seller acquired these shares via an open market purchase on 08/11/2020, with cash payment dated 08/13/2020. Company shares outstanding were 60,781,792. The notice represents the seller’s certification that they do not know of any undisclosed material adverse information about the issuer.